BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17487253)

  • 1. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD and co-morbidities, with special emphasis on cardiovascular conditions.
    Löfdahl CG
    Clin Respir J; 2008 Oct; 2 Suppl 1():59-63. PubMed ID: 20298351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation].
    Rossi FF; Pedone C; Antonelli Incalzi R
    Recenti Prog Med; 2011 Mar; 102(3):109-13. PubMed ID: 21572482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
    Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
    Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and inflammation - A further systemic complication of COPD.
    Bolton CE; Evans M; Ionescu AA; Edwards SM; Morris RH; Dunseath G; Luzio SD; Owens DR; Shale DJ
    COPD; 2007 Jun; 4(2):121-6. PubMed ID: 17530505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic obstructive pulmonary disease and cardiovascular disease].
    Alonso JL
    Arch Bronconeumol; 2010; 46 Suppl 3():18-22. PubMed ID: 20620688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation and metabolic syndrome in stable COPD patients.
    Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
    Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD).
    Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA
    Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.
    Biljak VR; Pancirov D; Cepelak I; Popović-Grle S; Stjepanović G; Grubišić TŽ
    Platelets; 2011; 22(6):466-70. PubMed ID: 21506665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z; Chen Y; Chen P; Wu G; Cai S
    Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Curr Opin Pulm Med; 2008 Mar; 14(2):115-21. PubMed ID: 18303420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.